Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lofexidine in Opioid Withdrawal Phenotyping
NCT05027919Phase 2Recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Dec 2021
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lofexidine in opioid withdrawal, sponsored by University of Maryland, Baltimore. Started Dec 2021; status: recruiting.
02
Drugs
lofexidine
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on NCT05027919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05027919.